EurekAlert! -
23 Feb 2018 07:00
(American Society for Biochemistry and Molecular Biology) New research published in the Feb. 23 issue of the Journal of Biological Chemistry identifies an enzyme that turns off transglutaminase 2, potentially paving the way for new treatments for celiac disease.
Share this Article